Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Benicar HCT Tablets, Sankyo Pharma, NDA 21-532 6/5/03 6/9/03 6/9/03 9/10/03 Benicar (olmesartan medoxomil) Tablets, 5, 20, and 40 mg, Sankyo Pharma, NDA 21-286/S2 2/12/03 2/25/03 Benicar (olmesartan medoxomil) Tablets, 5, 20, and 40 mg, Sankyo Pharma, NDA 21-286/S1 10/25/02 10/28/02 Benicar (olmesartan medoxomil) Tablets, 5, 20, and 40 mg, Sankyo Pharma, NDA 21-286 | Benicar (olmesartan medoxomil) Tablets, Sankyo Pharma Inc., Labeling Revision | Benicar HCT (olmesartan medoxomil/hydrochlorothiazide) Tablets, Sankyo Pharma Inc., Labeling Revision | Benicar (olmesartan medoxomil) Tablets, Sankyo Pharma, Inc., Labeling Revision | Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) Tablets, Sankyo Pharma, Inc., Labeling Revision Check the most up-to-date list of FDA Approvals.                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | FindingHealthOnline © 2010 Betterchem.com